why choose us

Clinical Trials Search

Showing 14,050 of 132,963 result(s)
Effect of Antioxidant Food Supplement on Sperm Proteomic Structure and Semen Parameters

Status: Completed

Condition: Asthenozoospermia

Interventions: Proxeed plus 2 x daily sachets (2*1) three mounths

Date: 2023-03-23

App-based Education and GOal-setting in Rheumatoid Arthritis

Status: Completed

Condition: Rheumatoid Arthritis

Interventions:

The self-management program, accessible via a smartphone app, comprises several components.
First, the app contains an RA-specific educational

Date: 2023-03-23

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

Status: Completed

Condition: NSCLC

Interventions: Atezolizumab will be given to participants intravenously at a dosage of 1200mg on Day 1 of each 21-day cycle, and on days 1 and 22 of concurrent chemo

Date: 2023-03-23

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Status: Completed

Condition: Aphakia

Interventions: Acrylic single-piece intraocular lens placed in the capsular bag in the posterior chamber of the eye during cataract surgery as a replacement for the

Date: 2023-03-23

A Study to Evaluate Safety and Efficacy of BIIB091 in Participants With Relapsing Forms of Multiple Sclerosis

Status: Completed

Condition: Relapsing Forms of Multiple Sclerosis

Interventions: Administered as specified in the treatment arm.

Date: 2023-03-23

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Status: Completed

Condition: Non-small Cell Lung Cancer

Interventions: Administered intravenously (IV) every 3 weeks (Q3W)

Date: 2023-03-23

Study of the Safety, Tolerability and Efficacy of NP-101 in Treating High Risk Participants Who Are Covid-19 Positive.

Status: Completed

Condition: COVID-19

Interventions: NP-101 is an organically derived, GMP manufactured product covered under IND #152687.

Date: 2023-03-23

Effects Of Income Supplements On 30-Day Readmissions For Vulnerable Older Adults

Status: Completed

Condition: Patient Readmission

Interventions: $300 income supplement

Date: 2023-03-23

Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma

Status: Completed

Condition: Multiple Myeloma

Interventions: Cycles 1, 3, 5, 7, etc. (odd numbered cycles): 1.9 mg;kg IV on Day 1 (28-day cycles)

Date: 2023-03-23

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Status: Completed

Condition: Anatomic Stage I Breast Cancer AJCC v8

Interventions: Given IV

Date: 2023-03-23